NanoViricides Nominates Novel Candidate for Advancing Into Clinical Trials for COVID-19 Treatment
NanoViricides Inc. (NYSEAmerican:NNVC) a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform,
Read More